Friday, September 26, 2014

New "Muscle-On-A-Chip" Could Enable Patient-Specific Asthma Treatments

Current methods of testing asthma drugs are often poor predictors of how they will perform in humans. To provide a tool for testing these drugs, Harvard researchers have developed a bench top test that uses human cells and may be more accurate than current methods.....

Read more here: meddeviceonline.com

------------------------------------------------------

Asthma's Treatment Pipeline Very Strong as More Personalized Medicines Emerge

Asthma has a very strong drug pipeline, with almost 100 novel molecules or formulations currently in Phases II and III of development, and the treatment landscape is moving towards a more personalized approach. Reportstack's report on Asthma - Global Drug Forecast and Market Analysis to 2023 states that the most significant challenge in asthma therapeutics is posed by patients with severe forms of the disease, who remain uncontrolled and have frequent exacerbations, even with the combination of high-dose inhaled corticosteroids (ICSs) and long-acting beta-agonists.....

Read more here: digitaljournal.com

------------------------------------------------------

Study shows stress and worry can lead to diagnosis of asthma

Worriers be warned.  As if those of us who are plagued with anxiety do not have enough to worry about, add one more thing to that list. According to the National Heart, Lung, and Blood Institute of the US National Institutes of Health (NIH), stresses and worry can contribute to adults developing asthma later in life.....

Read more here: modvive.com

No comments: